Hexagon Capital Partners LLC Bristol Myers Squibb CO Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 15,809 shares of BMY stock, worth $896,054. This represents 0.16% of its overall portfolio holdings.
Number of Shares
15,809
Previous 11,729
34.79%
Holding current value
$896,054
Previous $487,000
67.97%
% of portfolio
0.16%
Previous 0.11%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,535Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.7 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.99 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.27 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.42 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.46 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...